The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge
Titel:
The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge
Auteur:
Nicolini, Franck E. Chomel, Jean-Claude Roy, Lydia Legros, Laurence Chabane, Kaddour Ducastelle, Sophie Nicolas-Virelizier, Emmanuelle Michallet, Mauricette Tigaud, Isabelle Magaud, Jean-Pierre Turhan, Ali Guilhot, François Hayette, Sandrine